A Randomized, Double-blind, Placebo-controlled, Single-center, Single and Multiple Oral Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BF2.649 (pitolisant hydrochloride) in Healthy Japanese Adult Subjects
Phase 1
- Conditions
- narcolepsy
- Registration Number
- JPRN-jRCT2071210104
- Lead Sponsor
- Takuma Yonemura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 28
Inclusion Criteria
Healthy Japanese male volunteers aged 20 to 45 years
Exclusion Criteria
1. Individuals with a history of drug allergy, food allergy, allergic rash, asthma, intolerance or hypersensitivity to some drugs, or photosensitivity
2. Having alcohol or drug dependence etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method